743 related articles for article (PubMed ID: 24948493)
1. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
4. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
5. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
6. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Avanzas P; Bosa-Ojeda F; Kaski JC
Am J Cardiol; 2010 Dec; 106(11):1540-4. PubMed ID: 21094352
[TBL] [Abstract][Full Text] [Related]
8. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
[TBL] [Abstract][Full Text] [Related]
9. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction.
Balta S; Celik T; Ozturk C; Kaya MG; Aparci M; Yildirim AO; Demir M; Kilic S; Aydin İ; Iyisoy A
Am J Emerg Med; 2016 Aug; 34(8):1542-7. PubMed ID: 27238848
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
11. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Lei L; Ye H; Peng J
Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
[TBL] [Abstract][Full Text] [Related]
12. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
13. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
[TBL] [Abstract][Full Text] [Related]
14. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
15. Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction.
Yayla Ç; Akboğa MK; Canpolat U; Akyel A; Yayla KG; Doğan M; Yeter E; Aydoğdu S
Angiology; 2015 Oct; 66(9):831-6. PubMed ID: 25712290
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
[TBL] [Abstract][Full Text] [Related]
18. The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction.
Yildiz A; Yuksel M; Oylumlu M; Polat N; Akyuz A; Acet H; Aydin M; Ülgen MS
Clin Appl Thromb Hemost; 2015 Apr; 21(3):223-8. PubMed ID: 24431380
[TBL] [Abstract][Full Text] [Related]
19. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction.
Vakili H; Shirazi M; Charkhkar M; Khaheshi I; Memaryan M; Naderian M
Eur J Clin Invest; 2017 Apr; 47(4):322-327. PubMed ID: 28177528
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
